Job Title: CFO
Company: BCX
Cheryl-Jane Kujenga, also known as CJ, was appointed CFO of BCX in July 2023. Prior to this, she was a CFO in the pharmaceutical space at both Adcorp Holdings and Ascendis Health respectively. Cheryl-Jane served as acting COO of Adcorp Holdings from August 2017 to November 2017 and the interim CEO from October 2019 to April 2020. She has 20 years' commercial experience including nine years as a partner at EY. At EY, she was involved in an advisory capacity to various industries including technology, telecommunications, manufacturing, infrastructure, retail, healthcare and financial services and also served on the Accounting Standards Board (South Africa) for six years. She has an MBA from the University of Cape Town and a B.Compt Hons from UNISA. Cheryl was nominated for the 2020 CFO Awards.
Work
2023 – Present Chief Financial Officer, BCX
2023 – Present Non-Executive Director, Ster-Kinekor Theaters
2020 – 2022 Group Chief Financial Officer, Ascendis Health
2010 – 2020 Interim Chief Executive Officer, Adcorp Holdings
2017 – 2020 Group Chief Financial Officer, Adcorp Holdings
2008 – 2017 Partner & Strategic Growth Markets Leader, EY
2006 – 2008 Senior Manager, EY
2004 – 2006 Senior Manager, SizweNtsaluba VSP
2003 – 2004 Group Accountant / Head of Finance, NMB Bank Ltd Zimbabwe
Education
2016 – 2017 Executive MBA, Business Administration and Management, General, UCT.
1997 – 2000 B.Compt. Honours, Accounting, Audit, UNISA
1995 – 1996 Cambridge A levels, Maths, Physics, Chemistry, St Ignatius
About Ascendis Health Ltd: Ascendis Health is a market leader in health and care products, owning some of the most recognised brands in South Africa. Their innovative portfolio of products is spread across diverse revenue streams and markets, allowing for organic and strategic growth across each of their three product divisions: Ascendis Consumer Brands, Ascendis Pharma-Med and Ascendis Phyto-Vet.
Ascendis Health has more than 10 products sitting in the number one spot in the South African market, and a further 15 dominate the rankings in second position.
